Effects of Artificial Sweetener on Gastrointestinal (GI) Peptide Secretion

University Hospital Basel

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Dietary Supplement: Water; Dietary Supplement: Artificial sweeteners; Carbohydrate Sugars

Study type: Interventional

Funder types: Other

Identifiers

NCT00978900

EKBB 69/04

Details and patient eligibility

About

The purpose of this study is to examine the influence of artificial sweeteners (aspartame, acesulfame K, sucralose) and carbohydrate sugars (glucose, fructose) on the release of gastrointestinal satiety hormones in humans.

Full description

Artificial Sweeteners significantly lower energy density of foods and beverages. They are used by diabetics as sugar substitutes as well as by consumers as aids for dietary control. Despite numerous studies which show mainly no influence of artificial sweeteners on glucose metabolism and food intake, discrepancies consist about the real effects of artificial sweeteners. Studies by Blundell and Hill in 1986 have however shown that the consumption of artificial sweeteners resulted in an increase of appetite ratings; the efficiency of AS has therefore been questioned. With respect to the world wide increase in the prevalence in obesity, it seems important to clarify whether artificial sweeteners can help regulate body weight or not. This study will explore the effect of artificial sweeteners on the release of the gastrointestinal satiety hormones PYY, GLP-1, GIP and ghrelin.

Enrollment: 12 patients

Sex: All

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subject with a body-mass index of 19.0-24.5
• Normal eating habits
• Age 18-40 years
• Stable body weight for at least three months

Exclusion criteria

• Smoking
• Substance abuse
• Regular intake of medications (except for oral contraceptives)
• Medical or psychiatric illness
• history of gastrointestinal disorders
• food allergies

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Quadruple Blind

---

12 participants in 6 patient groups, including a placebo group

Acesulfame K

Active Comparator group

Treatment:

Dietary Supplement: Artificial sweeteners; Carbohydrate Sugars

Sucralose

Active Comparator group

Treatment:

Dietary Supplement: Artificial sweeteners; Carbohydrate Sugars

Aspartame

Active Comparator group

Treatment:

Dietary Supplement: Artificial sweeteners; Carbohydrate Sugars

Glucose

Active Comparator group

Treatment:

Dietary Supplement: Artificial sweeteners; Carbohydrate Sugars

Fructose

Active Comparator group

Treatment:

Dietary Supplement: Artificial sweeteners; Carbohydrate Sugars

Water

Placebo Comparator group

Treatment:

Dietary Supplement: Water